Protagonist Therapeutics Inc PTGX Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) Financials

Protagonist Therapeutics Inc (PTGX)

37.62

0.00

(0.00%)

Closed January 09 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-69.344	-28.68	-25.675	-52.439	-27.598	-37.357	-42.776	-26.063
Return on Equity (%)	-125.459	-35.504	-33.39	-80.203	-36.794	-43.321	-49.413	-28.592
Return on Invested Capital (%)	-130.818	-40.729	-37.678	-80.118	-36.063	-43.624	-51.001	-33.942
Operating Margin (%)	N/A	-184.205	-128.449	-33640.26	-224.42	-458.936	-479.263	-131.592
Net Profit Margin (%)	N/A	-184.205	-125.866	-33414.286	-231.067	-458.936	-479.263	-131.592
Book Value Per Share	5.236	5.72	4.853	2.938	6.392	6.272	4.37	5.837
Earnings Per Share	-2.257	-1.753	-1.679	-2.836	-1.512	-2.625	-2.582	-1.369
Cash Per Share	1.261	5.028	3.547	1.213	2.683	2.585	2.549	3.237
Working Capital Per Share	4.593	5.14	4.802	4.038	6.295	6.203	4.295	5.796
Operating Profit Per Share	N/A	0.951	1.334	0.008	0.654	0.572	0.539	1.04
EBIT Per Share	-2.223	-1.753	-1.713	-2.861	-1.482	-2.625	-2.582	-1.369
EBITDA Per Share	-2.223	-1.753	-1.713	-2.861	-1.482	-2.625	-2.582	-1.369
Free Cash Flow Per Share	-2.253	-1.74	-1.68	-2.826	-1.519	-2.618	-2.587	-1.375

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	16.72M	21.09M	23.19M	27.22M	43.75M	47.84M	49.34M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	49.2M	49.34M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	82.629	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	81.325	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.24B
Price to Earnings Ratio	-28.4
Price to Sales Ratio	37.37
Price to Cash Ratio	12.01
Price to Book Ratio	6.66
Dividend Yield	-

Share Statistics

Shares Outstanding	59.6M
Average Volume (1 week)	660.3k
Average Volume (1 Month)	665.82k
52 Week Change	65.51%
52 Week High	48.89
52 Week Low	22.66

More Ratios Coming Soon!

Protagonist Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions